Galli L - Search Results

1

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy.

Gianotti N, Galli L, Zazzi M, Ghisetti V, Bonora S, Micheli V, Meraviglia P, Corsi P, Bruzzone B, Menzo S, Di Giambenedetto S, De Luca A, Filice G, Penco G, Castagna A; ARCA database initiative. Gianotti N, et al. Among authors: galli l. J Med Virol. 2011 Mar;83(3):391-8. doi: 10.1002/jmv.21989. J Med Virol. 2011. PMID: 21264858

2

Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.

D'Amico A, Messa C, Castagna A, Zito F, Galli L, Pepe G, Lazzarin A, Lucignani G, Fazio F. D'Amico A, et al. Among authors: galli l. Nucl Med Commun. 1997 Aug;18(8):741-50. doi: 10.1097/00006231-199708000-00008. Nucl Med Commun. 1997. PMID: 9293505

3

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.

Uberti-Foppa C, De Bona A, Morsica G, Galli L, Gallotta G, Boeri E, Lazzarin A. Uberti-Foppa C, et al. Among authors: galli l. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52. doi: 10.1097/00126334-200306010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12794546 Clinical Trial.

4

Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.

Bagaglio S, Bruno R, Lodrini S, De Mitri MS, Andreone P, Loggi E, Galli L, Lazzarin A, Morsica G. Bagaglio S, et al. Among authors: galli l. J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):153-61. J Biol Regul Homeost Agents. 2003. PMID: 14518715 Clinical Trial.

5

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.

Gianotti N, Soria A, Galli L, Castagna A, Cernuschi M, Hasson H, Lazzarin A. Gianotti N, et al. Among authors: galli l. J Med Virol. 2004 Feb;72(2):181-6. doi: 10.1002/jmv.10580. J Med Virol. 2004. PMID: 14695657

6

Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.

Gianotti N, Soria A, Galli L, Giudici B, Fusetti G, Lazzarin A, Boeri E, Castagna A. Gianotti N, et al. Among authors: galli l. AIDS. 2004 Mar 26;18(5):821-3. doi: 10.1097/00002030-200403260-00018. AIDS. 2004. PMID: 15075522 No abstract available.

7

The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.

Castagna A, Gianotti N, Galli L, Danise A, Hasson H, Boeri E, Hoetelmans R, Nauwelaers D, Lazzarin A. Castagna A, et al. Among authors: galli l. Antivir Ther. 2004 Aug;9(4):537-43. Antivir Ther. 2004. PMID: 15456085 Clinical Trial.

8

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

Seminari E, Castagna A, Soldarini A, Galli L, Fusetti G, Dorigatti F, Hasson H, Danise A, Guffanti M, Lazzarin A, Rubinacci A. Seminari E, et al. Among authors: galli l. HIV Med. 2005 May;6(3):145-50. doi: 10.1111/j.1468-1293.2005.00278.x. HIV Med. 2005. PMID: 15876279 Free article.

9

Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.

Seminari E, Gentilini G, Galli L, Hasson H, Danise A, Carini E, Dorigatti F, Soldarini A, Lazzarin A, Castagna A. Seminari E, et al. Among authors: galli l. J Antimicrob Chemother. 2005 Oct;56(4):790-2. doi: 10.1093/jac/dki314. Epub 2005 Sep 5. J Antimicrob Chemother. 2005. PMID: 16143711

10

Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.

Uberti-Foppa C, De Bona A, Galli L, Sitia G, Gallotta G, Sagnelli C, Paties C, Lazzarin A. Uberti-Foppa C, et al. Among authors: galli l. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):63-7. doi: 10.1097/01.qai.0000192001.15777.15. J Acquir Immune Defic Syndr. 2006. PMID: 16340475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,189 results

Search Page

Filters